Bart Myers
13 years ago
Morgan Stanley is out with its report today on Medco Health Solutions (NYSE: MHS), maintaining Overweight.
In a note to clients, Morgan Stanley writes, "Framing a bear case scenario, if MHS were to retain only 92% of its ~$17 billion in revenues up for renewal (mirroring CVS' renewal rates in the 2009/2010 season) as compared to historical 99% retention rate, we quantify an EPS impact of ~ $0.10 to $0.15 to our 2012e EPS of $5.12. Under that scenario, ESRX may stand to gain share."
Source: http://www.benzinga.com/analyst-ratings/analyst-color/11/03/932746/morgan-stanley-maintains-overweight-on-medco-health-solut#ixzz1GrsdMy2h
ICEQUITY
14 years ago
MHS Investor Relations
Webcast Image Webcast - Replay
Medco Health Solutions, Inc. at Goldman Sachs Healthcare CEO's Conference
01/06/11 at 8:45 a.m. ET
Medco Health Solutions, Inc. at Goldman Sachs Healthcare CEO's Conference
Thursday, January 6, 2011 8:45 a.m. ET
Webcast PresentationHelp Help
Listen to the Webcast in Windows Media Player Listen to the Webcast in Real Player Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Webcast Image Webcast - Replay
Medco Health Solutions, Inc. at JP Morgan HealthCare Conference
01/10/11 at 10:30 a.m. PT
http://phx.corporate-ir.net/phoenix.zhtml?c=131268&p=irol-IRHome
ICEQUITY
14 years ago
VIPPS Accreditation Date September 10, 1999 Medco Health Solutions, Inc (MHS)
www.medco.com
Corporation
Medco Health Solutions, Inc
Phone
800-282-2881
Address
100 Parsons Pond Drive
Franklin Lakes, NJ 07417
State of Incorporation
DE Experience Operating a Pharmacy
Since March 1996
Dispensing Pharmacies
Pharmacy Name Address Click for Details
Medco at Home, LLC 14811 N Kierland Boulevard
Suite 600, Room 109
Scottsdale, AZ 85254 Click for Details
Medco Health Solutions of Columbus West, Ltd 255 Phillipi Road
Columbus, OH 43228 Click for Details
Medco Health Solutions of Dublin, Ltd 5151 Blazer Parkway, Suite B
Dublin, OH 43017 Click for Details
Medco Health Solutions of Fairfield 4865 Dixie Highway
Fairfield, OH 45014 Click for Details
Medco Health Solutions of Hidden River, LLC 8800 Hidden River Parkway
Tampa, FL 33637 Click for Details
Medco Health Solutions of Irving, L.L.C. 8111 Royal Ridge Parkway
Irving, TX 75063 Click for Details
Medco Health Solutions of Las Vegas, Inc 6225 Annie Oakley Drive
Las Vegas, NV 89120 Click for Details
Medco Health Solutions of Netpark, LLC 5701 E. Hillsborough Avenue, Suite 1300
Tampa, FL 33610 Click for Details
Medco Health Solutions of North Versailles, L.L.C. 1810 Lincoln Highway
North Versailles, PA 15137 Click for Details
Medco Health Solutions of Richmond, L.L.C. 9210 Forest Hill Avenue, Suite B2
Richmond, VA 23235 Click for Details
Medco Health Solutions of Spokane, Inc East 23102 Appleway Avenue
Liberty Lake, WA 99019 Click for Details
Medco Health Solutions of Texas, L.L.C 15001 Trinity Boulevard, Suite 300
Forth Worth, TX 76155 Click for Details
Medco Health Solutions of Willingboro, LLC One Millennium Drive
Willingboro, NJ 08046 Click for Details
To report medication / device problems:
Click www.medco.com or call 800-282-2881
To report business compliance problems:
Click www.medco.com or call 800-282-2881
Original VIPPS Accreditation Date Expiration Date
September 10, 1999 September 10, 2011
ICEQUITY
14 years ago
Medco MHS CEO to Present at Upcoming Healthcare Conferences
FRANKLIN LAKES, N.J., Jan. 3, 2011 /PRNewswire via COMTEX/ --
Medco Health Solutions, Inc. (NYSE: MHS) Chairman and CEO, David B. Snow Jr., is scheduled to present at the following healthcare conferences:
(Logo: http://photos.prnewswire.com/prnh/20100609/MEDCOLOGO)
The Goldman Sachs Healthcare CEOs Unscripted conference taking place in New York at the Goldman Sachs Conference Center on Thursday, January 6, 2011 at 8:45 a.m. ET;
The 29th Annual JPMorgan Healthcare Conference taking place in San Francisco at the Westin St. Francis Hotelon Monday, January 10, 2011 at 10:30 a.m. PT (1:30 p.m. ET).
Richard J. Rubino, chief financial officer, is also scheduled to attend.
The presentation may be heard live via a simulcast link and the accompanying slides will be available at www.medco.com/investor. Real Player or Windows Media Player is required to listen to the webcast. Free downloads of both players are available at the webcast site. The webcast will be available for replay for one month following the presentation.
About Medco
Medco Health Solutions, Inc. (NYSE: MHS) is pioneering the world's most advanced pharmacy(R) and its clinical research and innovations are part of Medco making medicine smarter(TM) for approximately 65 million members.
With more than 20,000 employees dedicated to improving patient health and reducing costs for a wide range of public and private sector clients, and 2009 revenues of nearly $60 billion, Medco ranks 35th on the Fortune 500 list and is named among the world's most innovative, most admired and most trustworthy companies.
For more information, go to http://www.medcohealth.com.
This press release contains "forward-looking statements" as that term is defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks and uncertainties that may cause results to differ materially from those set forth in the statements. No forward-looking statement can be guaranteed, and actual results may differ materially from those projected. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise. Forward-looking statements in this press release should be evaluated together with the risks and uncertainties that affect our business, particularly those mentioned in the Risk Factors section of the Company's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q filed with the Securities and Exchange Commission.
SOURCE Medco Health Solutions, Inc.
NYSE: MHS
Jan. 14, 2011/4:02 p.m. ET
(20 min. delay)
Last Trade $64.89
Change ($) - 0.05
Change (%) - 0.08%
Previous Close $64.94
Intraday High $65.01
Intraday Low $64.46
Volume 1,849,652
52 Week High $66.94
52 Week Low $43.45